Ruipeng Wang

2.1k total citations
64 papers, 1.5k citations indexed

About

Ruipeng Wang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ruipeng Wang has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Ruipeng Wang's work include Immune Cell Function and Interaction (8 papers), interferon and immune responses (5 papers) and HIV Research and Treatment (4 papers). Ruipeng Wang is often cited by papers focused on Immune Cell Function and Interaction (8 papers), interferon and immune responses (5 papers) and HIV Research and Treatment (4 papers). Ruipeng Wang collaborates with scholars based in China, United States and Japan. Ruipeng Wang's co-authors include Peter D. Sun, Zhonghe Zhai, Feici Diao, Danying Chen, Zhongcheng Zou, Hong‐Bing Shu, Min Zhang, Dong Gao, James P. Luyendyk and Yang Tian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ruipeng Wang

59 papers receiving 1.5k citations

Peers

Ruipeng Wang
Comparison fields: 5 of 124
  • Immunology 710
  • Molecular Biology 515
  • Oncology 221
  • Cancer Research 190
  • Epidemiology 185
Jia Yuan China
Xingyu Wang China
Dong Hyun Sohn South Korea
Camille Blériot France
Joanne Smith United Kingdom
Martina Molgora United States
Hui Song China
Peleg Rider Israel
David Frommhold Germany
Ran Zhuang China
Jia Yuan China View profile →
Citations per field, relative to Ruipeng Wang
Ruipeng Wang · 1×
Citations per year, relative to Ruipeng Wang
Ruipeng Wang · 1×

Countries citing papers authored by Ruipeng Wang

Since Specialization
Citations

This map shows the geographic impact of Ruipeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruipeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruipeng Wang more than expected).

Fields of papers citing papers by Ruipeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruipeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruipeng Wang. The network helps show where Ruipeng Wang may publish in the future.

Co-authorship network of co-authors of Ruipeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruipeng Wang. A scholar is included among the top collaborators of Ruipeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruipeng Wang. Ruipeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 3
4 3
5 0
6 1
7 1
8 8
9 10
10 11
11 25
12 12
13 9
14 8
15 3
16 17
17 1
18 53
19 26
20 111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026